to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Statistical and ethical issues in the design and conduct of phase I and II clinical trials of new anticancer agents.
Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups.
Development and use of integral assays in clinical trials.
How not to treat cancer.
Accrual to cancer clinical trials in the era of molecular medicine.
American Society of Clinical Oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy.
Enrollment Trends and Disparity Among Patients With Lung Cancer in National Clinical Trials, 1990 to 2012.
Precision cancer medicine: the future is now, only better.
Consensus statement on essential patient characteristics in systemic treatment trials for metastatic colorectal cancer: Supported by the ARCAD Group.
American Society of Clinical Oncology 2013 top five list in oncology.
Improving evidence developed from population-level experience with targeted agents.
Modernizing Eligibility Criteria for Molecularly Driven Trials.